METHYL 3-((3S)-7-BROMO-5-PYRIDIN-2-YL-2-(TRIFLUOROMETHYLSULFONYLOXY)-3H-1,4-BENZODIAZEPIN-3-YL)PROPANOATE
UNII 42E4A66TPS
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl 3-((3s)-7-bromo-5-pyridin-2-yl-2-(trifluoromethylsulfonyloxy)-3h-1,4-benzodiazepin-3-yl)propanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 42E4A66TPS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2242643-48-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H15BrF3N3O5S FSUOYCUKGAFQGO-HNNXBMFYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl 3-((3s)-7-bromo-5-pyridin-2-yl-2-(trifluoromethylsulfonyloxy)-3h-1,4-benzodiazepin-3-yl)propanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.